GeneDx Holdings Corp.
WGS
$70.69
-$4.81-6.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -424.86% | 8.14% | 137.05% | 67.74% | 121.10% |
| Total Depreciation and Amortization | 28.40% | 9.19% | 18.65% | 8.19% | 1,020.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 251.01% | 429.10% | -57.56% | 22.70% | -352.54% |
| Change in Net Operating Assets | 103.38% | 50.10% | -360.64% | 143.62% | 7.21% |
| Cash from Operations | 2.92% | 458.75% | 331.30% | 162.04% | 89.34% |
| Capital Expenditure | -42.52% | -855.42% | -75.22% | -1,283.52% | -28.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -379.10% | 120.89% | 96.32% | -354.98% | 196.05% |
| Cash from Investing | -2,033.33% | 39.56% | -60.13% | -1,216.01% | 89.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 55.37% | -71.99% | -61.55% | -97.19% | -4.30% |
| Issuance of Common Stock | -26.65% | -18.34% | 775.18% | 60,854.17% | 171,221.05% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -25.24% | -22.91% | 188.49% | 3,231.96% | -34.14% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -66.94% | 1,101.76% | 7.29% | 190.53% | 120.67% |